Cargando…

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

To determine potential predictors of long‐term survival in a large set of Hispanic (Mexican) patients with chronic myeloid leukemia (CML) treated with imatinib. We conducted an analysis with data from 411 patients with CML treated at the National Cancer Institute – Mexico, between January 2000 and D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ylescas‐Soria, Jimena, de la Torre‐Lujan, Alfredo H., Herrera, Luis A., Miranda, Daniela, Grimaldo, Flavio, Rivas, Silvia, Cervera, Eduardo, Meneses‐García, Abelardo, Leon-Sarmiento, Fidias E., Prada, Diddier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558595/ https://www.ncbi.nlm.nih.gov/pubmed/31050162 http://dx.doi.org/10.1002/cam4.2201

Ejemplares similares

Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic Stimulation
por: Leon-Sarmiento, Fidias E., et al.
Publicado: (2019)

Imatinib: a new chemopreventive option in adenomatous polyposis?
por: Tobon, Angelica, et al.
Publicado: (2020)

Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population––A SEER‐based analysis from 2000 to 2016
por: Taylor, Melissa A., et al.
Publicado: (2021)

Analyzing non‐cancer causes of death of colorectal carcinoma patients in the US population for the years 2000–2016
por: Lu, Lili, et al.
Publicado: (2020)

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
por: Abou Dalle, Iman, et al.
Publicado: (2019)

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer
por: Wang, Qing, et al.
Publicado: (2021)

A hypoxia-related prognostic model predicts overall survival and treatment response in hepatocellular carcinoma
por: Xing, Jiyuan, et al.
Publicado: (2022)

Progress in reducing premature mortality from cancer and cardiovascular disease in the former Soviet Union, 2000–19
por: Znaor, Ariana, et al.
Publicado: (2022)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
por: Zhuang, Wei, et al.
Publicado: (2018)

Overall economic perspective to the year 2000 /
Publicado: (1988)

Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
por: Marcus, Julia L., et al.
Publicado: (2020)

The Epigenetic Origin of Aneuploidy
por: Herrera, Luis A, et al.
Publicado: (2008)

Oral hygiene and the overall survival of head and neck cancer patients
por: Chang, Chan‐Chi, et al.
Publicado: (2019)

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib
por: Avilés‐Vázquez, Sócrates, et al.
Publicado: (2017)

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
por: Watts, Eleanor L, et al.
Publicado: (2022)

Pericentromeric demethylation and chromosomal instability induced by chemicals
por: Prada, Diddier, et al.
Publicado: (2007)

Is this environment making you older? Molecular biomarkers and new approaches to investigate the influences of environmental chemicals through aging
por: Prada, Diddier, et al.
Publicado: (2021)

Overall view of Point 5 in Cessy (Oct 2000)
Publicado: (2000)

Cancer Trends in Iraq 2000–2016
por: Hussain, Ashraf MA., et al.
Publicado: (2021)

PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
por: Abbas, Rime, et al.
Publicado: (2015)

A survey of overall life satisfaction and its association with breast diseases in Chinese women
por: Bai, Aili, et al.
Publicado: (2015)

Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes
por: Xu, Amy J., et al.
Publicado: (2019)

Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
por: Ter‐Minassian, Monica, et al.
Publicado: (2017)

Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer Registry
por: Schonfeld, Sara J., et al.
Publicado: (2016)

Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission
por: Dumas, Pierre‐Yves, et al.
Publicado: (2019)

The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center
por: Renberg, Sara, et al.
Publicado: (2022)

Establishment of a nine‐gene prognostic model for predicting overall survival of patients with endometrial carcinoma
por: Ying, Jianchao, et al.
Publicado: (2018)

Sleep duration and risk of overall and 22 site‐specific cancers: A Mendelian randomization study
por: Titova, Olga E., et al.
Publicado: (2020)

Improving the overall survival prognosis prediction accuracy: A 9‐gene signature in CRC patients
por: Zheng, Wenbo, et al.
Publicado: (2021)

Signature based on metabolic‐related gene pairs can predict overall survival of osteosarcoma patients
por: Li, Long‐Qing, et al.
Publicado: (2021)

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
por: Casado, Luis-Felipe, et al.
Publicado: (2015)

Gastric and esophageal cancer in China 2000 to 2030: Recent trends and short‐term predictions of the future burden
por: Zhou, Jiachen, et al.
Publicado: (2022)

Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor
por: Liu, Xuechao, et al.
Publicado: (2022)

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
por: Naso, Julia R., et al.
Publicado: (2020)

Estimation of Overall Survival with Subsequent Treatment Effect by Applying Inverse Probability of Censoring Weighting in the LATITUDE Study
por: Koroki, Yosuke, et al.
Publicado: (2022)

Living with Bladder Cancer: Self-reported Changes in Patients’ Functional and Overall Health Status Following Diagnosis
por: Ungerer, Garrett, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l00eb5s84ida50f40po41vmovc